Shandong Boyuan Pharmaceutical & Chemical Co., Ltd.'s latest marketcap:
As of 06/25/2025, Shandong Boyuan Pharmaceutical & Chemical Co., Ltd.'s market capitalization has reached $687.32 M. According to our data, Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. is the 11682th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 687.32 M |
| Revenue (ttm) | 186.96 M |
| Net Income (ttm) | 29.44 M |
| Shares Out | 102.8 M |
| EPS (ttm) | 0.27 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 05/26/2025 |
| Earnings Date | 07/25/2025 |
Shandong Boyuan Pharmaceutical & Chemical Co., Ltd.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/25/2025 | ¥687.32 M | 8.5% | 11682 |
| 12/31/2024 | ¥5.27 B | 10643 |
Company Profile
Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. engages in the research and development, production, and sales of fine chemicals.
The company offers iodine derivatives, such as potassium iodide, sodium iodide, potassium iodide, hydriodic acid, copper iodide, and iodotrimethylsilane; and fine chemicals, including hexamethyldisilazane, hexamethyldisilane, hexamethyldisiloxane, and tris[2-(2-methoxyethoxy)ethyl]amine.
It also offers chemiluminescent products comprising 3,5-Dichlorosalicylic acid; 3,5,6-Trichlorosalicylic acid; bis(2,4,5-trichloro-6-carbopentoxyphenyl) oxalate; and Bis(2,4,5-trichloro-6-i-pentoxycarbonylphenyl) oxalate.
In addition, the company provides precious metal catalysts, such as rhodium(ii) octanoate dimer, rhodium(iii) iodide, wilkinson’s catalyst, palladium acetate, rhodium(iii) chloride hydrate, palladium chloride, chloroplatinic acid hexahydrate, potassium platinochloride, potassium hexachloroplatinate, ruthenium(iii) chloride hydrate, rhodium (triphenylphosphine)carbonylacetylacetonate, tetrakis(triphenylphosphine)palladium, palladium on carbon, and ruthenium on carbon.
Its products are used in pharmaceutical, chemical, optoelectronic materials, feed, food, and other fields.
The company was founded in 2008 and is based in Shouguang, China.
Frequently Asked Questions
-
What is Shandong Boyuan Pharmaceutical & Chemical Co., Ltd.'s (SHE-301617) current market cap?As of 06/25/2025, Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (including the parent company, if applicable) has an estimated market capitalization of $687.32 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE-301617) rank globally by market cap?Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. global market capitalization ranking is approximately 11682 as of 06/25/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.